Our new Cryptocurrency section has arrived! Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.00
Bid: 30.50
Ask: 31.50
Change: 0.00 (0.00%)
Spread: 1.00 (3.28%)
Open: 31.00
High: 31.00
Low: 30.50
Yest. Close: 31.00
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

WINNERS & LOSERS SUMMARY: Intu Properties Up As Consortium Makes Offer

Fri, 19th Oct 2018 10:50

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

FTSE 100 - WINNERS

London Stock Exchange Group, up 1.2%. LSEG said it will acquire a further 15% of LCH, taking its ownership to 80%. LSEG said the total cash consideration for the acquisition will be up to a maximum of EUR438 million. The acquisition will be funded from cash and existing debt facilities. The deal is expected to close before the end of 2018. In addition, for the three months ended September, LSEG reported a 7.4% increase in total income to GBP522 million from GBP486 million in the same period a year ago. The company's net revenue, which excludes income from the company's central counterparty business, increased 4.7% to GBP464 million from GBP443 million. LSEG's third-quarter gross profit increased 8.1% year-on-year to GBP465 million from GBP430 million.

Evraz up 0.2%. The steel producer said its ongoing efficiency programme will result in a USD290 million to USD300 million gain on earnings before interest, taxes, depreciation and amortisation basis for 2018. Evraz is targeting to maintain its cost savings to improve cost of sales by at least 3% or around USD250 million to USD300 million per annum going forward. The company, which is holding an investor day on Friday, is considering four major investment projects to increase sales of finished steel products to local markets in In 2019 to 2022 period. It plans to invest between USD830 to USD990 million per annum during the period. For 2018, Evraz is guiding capital expenditure of USD640 million to USD660 million.

FTSE 100 - LOSERS

Intercontinental Hotels Group, down 7.0%. The hotel operator reported 1.0% rise in revenue per available room for the third quarter ended September, resulting from a 1.7% rise in room rates, offset by a 0.7% dip in occupancy. In Europe, Middle East, Asia & Africa, RevPAR was up 2.5% boosted by a good performance from Continental Europe, which saw RevPAR up 4.3%. EMEAA room rates were up 2.2% and occupancy by 0.3%. Also in Greater China RevPAR increased up 4.8% driven by continued transient and corporate demand, with room rates higher by 3.6% and occupancy by 1.2%. In addition, IHG said it will pay a USD500 million special dividend with a share consolidation in the first quarter of 2019.

FTSE 250 - WINNERS

intu Properties, up 12%. The property group confirmed that it had received a takeover proposal from a consortium comprising Peel Group, Olayan Group, and Brookfield Property Group. On Wednesday, intu received a revised proposal from the consortium of 215p per share in cash, it said. The terms of both the initial and revised proposals provide that the mooted consideration will be reduced by any dividends declared or paid by intu prior to completion of the deal. This includes intu's interim dividend of 4.6p per share, due to be paid in November. Accordingly, the consideration under the revised proposal would be 210.4p per share. That price values intu at GBP2.85 billion.

Dechra Pharmaceuticals, up 4.7%. The group said that its trading in the first quarter was in line with management views with both units EU Pharmaceuticals and NA Pharmaceuticals recording "above market growth". The company said it is confident in the "continued out-performance" of the markets where it operates. In a separate announcement, Dechra said it bought Brazil-based Laboratorios Vencofarma for GBP37.8 million. Venco, which owns a portfolio of vaccines and food producing animal products, recorded GBP11.6 million in revenue for 2017. The firm, based in Londrina, Brazil, also owns a small range of companion animal products vaccines and pharmaceuticals.

IP Group, up 2.3%. Berenberg initiated the intellectual property company with a Buy rating, and a target price of 160 pence.

FTSE 250 - LOSERS

Renishaw, down 7.4%. On Thursday, the engineering company reported a fall in pretax profit for the three months to the end of September by 9.2% to GBP33.5 million from GBP36.9 million in the first quarter of 2018. Renishaw's total revenue increased 8.2% to GBP154.0 million from GBP142.3 million in the same period last year. The company's Metrology division increased its revenue 7.5% in the first quarter to GBP147.4 million from GBP137.1 million. The company said it remains confident in its future prospects despite the "potential impacts" of Brexit and the "economic uncertainties" in Asia.

Essentra, down 3.6%. The packaging and plastic products manufacturer said it will record a GBP12 million exceptional charge in the second half of 2018 due to the intended closure of the commercial print and consumer packaging site in Largo, US, as well as consultation processes at the company's commercial print facility in Kilmarnock and Nottingham in the UK. The Largo facility in Florida is expected to close by the end of 2018 and, if the proposals in the UK are confirmed, the Kilmarnock site would close and Speciality Tapes cease production in Nottingham by the same time.

OTHER MAIN MARKET AND AIM - WINNERS

Photonstar LED Group, up 15%. The LED lighting manufacturer has entered a partnership with a major housing association in the south of England to conduct a trial to assess the scalability of a number of products within Photonstar's V2 halcyon cloudBMS product suite to increase safety. The applications to be tested by the trial includes energy monitoring, critical assets monitoring, emergency lighting remote testing, temperature monitoring of water systems to reduce legionella risk and general environmental monitoring.

Safestyle UK, up 14%. The windows and doors maker has confirmed that it is not in talks to acquire NIAMAC Developments, trading as SafeGlaze UK, or any of its business or assets. The board said it it is considering "other arrangements" with NIAMAC that could accelerate Safestyle's recovery.

OTHER MAIN MARKET AND AIM - LOSERS

Rockfire Resources, down 29%. The exploration company reported its reverse circulation drilling results at Marengo in Queensland, Australia, with the blind geophysical anomalies beneath and to the northeast of One Mile Mountain containing up to 1-2% pyrite, but hosts significant gold or copper in the two holes drilled.

Futura Medical, down 27%. The sexual health-focused pharmaceutical company raised GBP5.6 million through a placing, subscription and open offer of shares at 7.0 pence per share. The price reflects a discount of 28% to Thursday's closing price of 9.65 pence. Proceeds will go towards funding its topical erectile dysfunction gel through to a phase three trial. The funds are also expected to allow more headroom in a long-term open label arm of the study, and to allow a second phase three trial to take place.

Webis Holdings, down 18%. The pool wagering specialist said its US business, WatchandWager.com LLC has no choice but to end its wagering services to a syndicate following a commercial dispute. As a result, WatchandWager have refunded the syndicate's player balances, totalling USD10 million. This is expected to reduce Webis' gross margin for the year ending May 2019 by USD800,000.

More News

Futura Medical Doses Final Patient In Erectile Dysfunction Drug Study

Futura Medical Doses Final Patient In Erectile Dysfunction Drug Study

21 Oct 19 15:16

Futura Medical Shares Drop As Interim Costs Surge Amid Clinical Trial

(Alliance News) - Shares in pharmaceutical firm Futura Medical PLC dropped sharply Wednesday after interim losses worsened amid rising development costs, whilst it continues to progress key in 11%

11 Sep 19 11:21

Futura Medical sees 'good progress' despite regulatory delays

(Sharecast News) - Pharmaceutical company Futura Medical told investors at its annual general meeting on Monday that it had continued to make "good progress" in developing and commercialising its pipeline of product opportunities despite regulatory delays to the advancement of its pain relief gel.

24 Jun 19 09:27

Futura Medical recruits 1,000 patients for erectile treatment trial

(Sharecast News) - Pharmaceutical company Futura Medical announced the completion of patient recruitment for the first European phase 3 study of MED2005, 'FM57', on Wednesday, adding that it remained on track to deliver headline data by the end of 2019.

19 Jun 19 09:58

UK Shareholder Meetings Calendar - Next 7 Days

Tuesday 18 JunePlus500Horizon Discovery GroupClearstarCoca-Cola 19 20 Property (re of

17 Jun 19 16:02

Monday broker round-up

(Sharecast News) - Hammerson: Peel Hunt upgrades to add with a target price of 350p.

17 Jun 19 12:21

Futura Medical Annual Loss Widens On Higher Research Costs

LONDON (Alliance News) - Futura Medical PLC on Wednesday reported a widened annual loss widened as the company continued to focus on its lead erectile dysfunction treatment MED2005.Futura a

10 Apr 19 11:06

Futura Medical Enrol First Patient To Late Stage MED2002 Clinical Test

LONDON (Alliance News) - Pharmaceutical firm Futura Medical PLC said Wednesday it has enrolled its first patient on a late-stage clinical trial of its MED2002 erectile dysfunction is a topical gel

31 Oct 18 11:16

WINNERS & LOSERS SUMMARY: Intu Properties Up As Consortium Makes Offer

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------London Stock a

19 Oct 18 10:50

Futura Medical Shares Drop 27% After Discounted Placing And Open Offer

LONDON (Alliance News) - Shares in Futura Medical PLC plunged on Friday after it said that it raised GBP5.6 million via a share placing, subscription and an open offer at a discounted company 80 7

19 Oct 18 10:30

Futura Raising GBP6 Million For Erectile Dysfunction Gel Trial (ALLISS)

LONDON (Alliance News) - Futura Medical PLC on Thursday said it is placing to raise no less than GBP5 million via an accelerated bookbuild and up to an additional GBP1 million through an open will

18 Oct 18 17:39

Futura Medical focused on 'excellent' developments as losses deepen

(Sharecast News) - Pharmaceutical group Futura Medical on Wednesday reported an "excellent" first-half as it continued to make progress on the development of two of its main products.

26 Sep 18 16:14

Futura Medical Interim Loss Deepens As Revenue Fades, Costs Grow

LONDON (Alliance News) - Healthcare firm Futura Medical PLC said Wednesday its interim loss deepened after revenue disappeared and costs rose, as it continued to make progress on the development 3

26 Sep 18 10:59

Futura Medical Shares Down As Phase-Three Data Required For MED2002

LONDON (Alliance News) - Shares in Futura Medical PLC plunged on Wednesday after reporting that potential partners for the licensing of MED2002 have asked for further tests on the product before a

19 Sep 18 11:40

UK Earnings, Trading Statements Calendar - Next 7 Days

Thursday 6 September PPHE Hotel GroupHalf Year ResultsHunters PropertyHalf Year Year Year

5 Sep 18 16:13

Login to your account

Don't have an account? Click here to register.